WATER FOR INJECTION, STERILE

The contract, awarded to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) under delivery order SPE2D226F3054 and issued against the master IDIQ contract SPE2DX25D9822, is a firm-fixed-price acquisition for 2.000 PG of WATER FOR INJECTION, STERILE (NSN 6505012870627) at a total price of $218.40. The award was issued on July 16, 2026, with delivery required by the same date and governed by FOB DESTINATION terms, where the contractor assumes all freight costs and risk of loss until delivery at the destination. The contract relies entirely on commercial item procedures under FAR Part 12, incorporating essential clauses including 52.212-1, 52.212-3, 52.212-4, and 52.212-5, which define offeror representations, commercial item terms, and statutory compliance requirements without additional technical specifications or MIL-STD references. The NAICS code 325412 identifies the contractor’s industry as pharmaceutical preparation manufacturing, and the acquisition is classified as a small business set-aside eligible for HUBZone, service-disabled veteran-owned, women-owned, and economically disadvantaged women-owned small businesses, although no offeror certifications are documented within the provided materials. The Defense Logistics Agency’s Troop Support branch administers the contract through Contracting Officer Lorinda Ferraiolo, with payments processed by the Defense Finance and Accounting Service in Columbus, Ohio, using Standard Form 1449 and no explicit invoicing system specified. Inspection and acceptance occur at the destination by government representatives, and while shipment must be via fastest traceable means and prohibits parcel post, no detailed packaging, preservation, or marking standards beyond identifiers like CLIN, CAGE code, NDC, and TCN are prescribed. The contract’s $218.40 value reflects only this single delivery order under a larger $20 million IDIQ vehicle with no options, modifications, or special requirements documented, indicating a streamlined commercial acquisition focused on rapid, compliant delivery of a critical sterile medical product.